Leukocyte antigen-related inhibition attenuates palmitate-induced insulin resistance in muscle cells

Journal of Endocrinology

Volumn 215, Issue 1, 2012, Pages 71-77

  Gorgani Firuzjaee, Sattar ^a   Bakhtiyari, Salar ^b   Golestani, Abolfazl ^a   Meshkani, Reza ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; DEOXYGLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PALMITIC ACID; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; DEOXYGLUCOSE; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; INSULIN RESISTANCE; MICE; MUSCLE CELLS; MUSCLE FIBERS, SKELETAL; ONCOGENE PROTEIN V-AKT; PALMITIC ACID; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RNA, MESSENGER; UP-REGULATION;

EID: 84869231865     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0160     Document Type: Article

References (34)

1. Ahmad F, Considine RV & Goldstein BJ 1995 Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. Journal of Clinical Investigation 95 2806-2812.
2. Ahmad F, Azevedo JL, Cortright R, Dohm GL & Goldstein BJ 1997 Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. Journal of Clinical Investigation 100 449-458.
3. Bakhtiyari S, Meshkani R, Taghikhani M, Larijani B & Adeli K 2010 Protein tyrosine phosphatase-1B (PTP-1B) knockdown improves palmitate-induced insulin resistance in C2C12 skeletal muscle cells. Lipids 45 237-244.
4. Björnholm M, Kawano Y, Lehtihet M & Zierath JR 1997 Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46 524-527.
5. Calera MR, Vallega G & Pilch PF 2000 Dynamics of protein-tyrosine phosphatases in rat adipocytes. Journal of Biological Chemistry 275 6308-6312.
6. Chagnon MJ, Uetani N & Tremblay ML 2004 Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochemistry and Cell Biology 82 664-675.
7. Chavez JA & Summers SA 2003 Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Archives of Biochemistry and Biophysics 419 101-109.
8. Coll T, Eyre E, Rodríguez-Calvo R, Palomer X, Sánchez RM, Merlos M, Laguna JC & Vázquez-Carrera M 2008 Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. Journal of Biological Chemistry 283 11107-11116.
9. Czech MP 2002 Fat targets for insulin signaling. Molecular Cell 9 695-696.
10. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL et al. 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. Journal of Clinical Investigation 103 253-259.
11. Esposito DL, Li Y, Cama A & Quon MJ 2001 Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulinstimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 142 2833-2840.
12. Force T, Kuida K, Namchuk M, Parang K & Kyriakis JM 2004 Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease. Circulation 109 1196-1205.
13. Goldstein BJ, Bittner-Kowalczyk A, White MF & Harbeck M 2000 Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. Journal of Biological Chemistry 275 4283-4289.
14. Hirata AE, Alvarez-Rojas F, Campello Carvalheira JB, de Oliveira Carvalho CR, Dolnikoff MS & Abdalla Saad MJ 2003 Modulation of IR/PTP1B interaction and downstream signaling in insulin sensitive tissues of MSG-rats. Life Sciences 73 1369-1381.
15. den Hertog J, Ostman A & Böhmer FD 2008 Protein tyrosine phosphatases: regulatory mechanisms. FEBS Journal 275 831-847.
16. Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G & Olefsky JM 2002 Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. Journal of Clinical Endocrinology and Metabolism 87 226-234.
17. Kulas DT, Zhang WR, Goldstein BJ, Furlanetto RW & Mooney RA 1995 Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. Journal of Biological Chemistry 270 2435-2438.
18. Kulas DT, Goldstein BJ & Mooney RA 1996 The transmembrane protein-tyrosine phosphatase LA Rmodulates signaling by multiple receptor tyrosine kinases. Journal of Biological Chemistry 271 748-754.
19. Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA &Watt MJ 2006 Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. Journal of Applied Physiology 100 1467-1474.
20. Mander A, Hodgkinson CP & Sale GJ 2005 Knock-down of LAR protein tyrosine phosphatase induces insulin resistance. FEBS Letters 579 3024-3028.
21. Meshkani R & Adeli K 2009 Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clinical Biochemistry 42 1331-1346.
22. MohammadTaghvaei N, Meshkani R, Taghikhani M, Larijani B & Adeli K 2011 Palmitate enhances protein tyrosine phosphatase 1B (PTP1B) gene expression at transcriptional level in C2C12 skeletal muscle cells. Inflammation 34 43-48.
23. MohammadTaghvaei N, Taheripak G, Taghikhani M & Meshkani R 2012 Palmitate-induced PTP1B expression is mediated by ceramide-JNK and nuclear factor kB (NF-kB) activation. Cellular Signalling 24 1964-1970.
24. Mooney RA, Kulas DT, Bleyle LA & Novak JS 1997 The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation. Biochemical and Biophysical Research Communications 235 709-712.
25. Norris K, Norris F, Kono DH, Vestergaard H, Pedersen O, Theofilopoulos AN & Møller NP 1997 Expression of protein-tyrosine phosphatases in the major insulin target tissues. FEBS Letters 415 243-248.
26. Parvaneh L, Meshkani R, Bakhtiyari S, Mohammadtaghvaie N, Gorganifiruzjaee S, Taheripak G, Golestani A, Foruzandeh M, Larijani B & Taghikhani M 2010 Palmitate and inflammatory state additively induce the expression of PTP1B in muscle cells. Biochemical and Biophysical Research Communications 396 467-471.
27. Pessin JE & Saltiel AR 2000 Signaling pathways in insulin action: molecular targets of insulin resistance. Journal of Clinical Investigation 106 165-169.
28. Reaven GM 1988 Role of insulin resistance in human disease. Diabetes 37 1595-1607.
29. Ren JM, Li PM, Zhang WR, Sweet LJ, Cline G, Shulman GI, Livingston JN & Goldstein BJ 1998 Transgenic mice deficient in the LAR proteintyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes 47 493-497.
30. Reynoso R, Salgado LM & Calderon V 2003 High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Molecular and Cellular Biochemistry 246 155-162.
31. Schaapveld RQ, Schepens JT, Robinson GW, Attema J, Oerlemans FT, Fransen JA, Streuli M, Wieringa B, Hennighausen L & Hendriks WJ 1997 Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Developmental Biology 188 134-146.
32. Storz P, Doppler H, Wernig A, Pfizenmaier K & Muller G 1999 Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. European Journal of Biochemistry 266 17-25.
33. Svedberg J, Björntorp P, Smith U & Lönnroth P 1990 Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39 570-574.
34. Zabolotny JM, Kim YB, Peroni OD, Kim JK, Pani MA, Boss O, Klaman LD, Kamatkar S, Shulman GI, Kahn BB et al. 2001 Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance. PNAS 98 5187-5192.